COCP
Cocrystal Pharma, Inc.Company with tickers: COCP
CIK
1412486
CUSIP
19188J409
Shares Outstanding
13,787,453
Website
https://www.cocrystalpharma.com
Investor Relations
https://ir.cocrystalpharma.com/
13F Activity (30d)
8 filings
8 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| James Sapirstein | Chief Executive Officer | Appointed | 2026-06-09 |